Evidence map›Paper›PMID 35911712›Full record

ArticleFrontiers in immunology2022

Complement Is Activated During Normothermic Machine Perfusion of Porcine and Human Discarded Kidneys.

Neeltina M Jager, Leonie H Venema, Asel S Arykbaeva, Anita H Meter-Arkema, Petra J Ottens, Cees van Kooten, Tom E Mollnes, Ian P J Alwayn, Henri G D Leuvenink, Soeren E Pischke and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Neeltina M JagerDepartment of Surgery, University Medical Center Groningen, Groningen, Netherlands.
Leonie H VenemaDepartment of Surgery, University Medical Center Groningen, Groningen, Netherlands.
Asel S ArykbaevaLUMC Transplant Center, Department of Surgery, Leiden University Medical Center, Leiden, Netherlands.
Anita H Meter-ArkemaDepartment of Nephrology, University Medical Center Groningen, Groningen, Netherlands.
Petra J OttensDepartment of Surgery, University Medical Center Groningen, Groningen, Netherlands.
Cees van KootenLUMC Transplant Center, Department of Nephrology, Leiden University Medical Center, Leiden, Netherlands.
Tom E MollnesDepartment of Immunology, University of Oslo and Oslo University Hospital Rikshospitalet, Oslo, Norway.
Ian P J AlwaynLUMC Transplant Center, Department of Surgery, Leiden University Medical Center, Leiden, Netherlands.
Henri G D LeuveninkDepartment of Surgery, University Medical Center Groningen, Groningen, Netherlands.
Soeren E PischkeDepartment of Immunology, University of Oslo and Oslo University Hospital Rikshospitalet, Oslo, Norway.
PROPER study consortium
University Medical Center Groningen · NLLeiden University Medical Center · NLUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The gap between demand and supply of kidneys for transplantation necessitates the use of kidneys from extended criteria donors. Transplantation of these donor kidneys is associated with inferior results, reflected by an increased risk of delayed graft function. Inferior results might be explained by the higher immunogenicity of extended criteria donor kidneys. Normothermic machine perfusion (NMP) could be used as a platform to assess the quality and function of donor kidneys. In addition, it could be useful to evaluate and possibly alter the immunological response of donor kidneys. In this study, we first evaluated whether complement was activated during NMP of porcine and human discarded kidneys. Second, we examined the relationship between complement activation and pro-inflammatory cytokines during NMP. Third, we assessed the effect of complement activation on renal function and injury during NMP of porcine kidneys. Lastly, we examined local complement C3d deposition in human renal biopsies after NMP. Methods: NMP with a blood-based perfusion was performed with both porcine and discarded human kidneys for 4 and 6 h, respectively. Perfusate samples were taken every hour to assess complement activation, pro-inflammatory cytokines and renal function. Biopsies were taken to assess histological injury and complement deposition. Results: Complement activation products C3a, C3d, and soluble C5b-9 (sC5b-9) were found in perfusate samples taken during NMP of both porcine and human kidneys. In addition, complement perfusate levels positively correlated with the cytokine perfusate levels of IL-6, IL-8, and TNF during NMP of porcine kidneys. Porcine kidneys with high sC5b-9 perfusate levels had significantly lower creatinine clearance after 4 h of NMP. In line with these findings, high complement perfusate levels were seen during NMP of human discarded kidneys. In addition, kidneys retrieved from brain-dead donors had significantly higher complement perfusate levels during NMP than kidneys retrieved from donors after circulatory death. Conclusion: Normothermic kidney machine perfusion induces complement activation in porcine and human kidneys, which is associated with the release of pro-inflammatory cytokines and in porcine kidneys with lower creatinine clearance. Complement inhibition during NMP might be a promising strategy to reduce renal graft injury and improve graft function prior to transplantation.

Indexed as

KidneyOrgan PreservationAnimalsComplement System ProteinsCreatinineCytokinesHumansPerfusionSwineComplement System ProteinsCreatinineCytokinescomplement systemimmunologyischemia-reperfusion injurykidney transplantationnormothermic machine perfusion

Identifiers

PMID35911712
PMCPMC9327788
OpenAlexW4285392353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.